Co-Agonism of GLP-1R and CTR/AMYR in the Lateral Dorsal Tegmental Nucleus Produces Additive Effects on Homeostatic and Motivated Feeding.

Physiology & behavior

Development and validation of a multiplexed LC-HRMS method for nine GLP-1 receptor agonists and its pharmaceutical application.

Journal of chromatography. A

Effect of tirzepatide and semaglutide on blood pressure: A systematic review and meta-analysis.

Endocrine

GLP-1-based incretin therapy is associated with lower incident Alzheimer's disease and cardiorenal events in adults with documented neuropsychiatric, cognitive, or sensory risk.

Biology methods & protocols

Maximizing Metabolic Synergy: A Review of Dual Incretin Therapy as a Step-Up Strategy Following Glucagon-Like Peptide-1 (GLP-1) Monotherapy Failure or Optimization.

Cureus

Glucagon-like peptide-1 and peptide YY multi-agonism with GEP44 to optimize weight loss and glycemic control while reducing gastrointestinal side effects: the future of anti-obesity pharmacotherapy?

Frontiers in endocrinology

Validation of a Pharmacist-Led Semaglutide Prescribing Algorithm for Type 2 Diabetes and Chronic Kidney Disease: Research Letter.

Canadian journal of kidney health and disease

Liver Organoids: From Disease Modelling to Regenerative Medicine.

Cell proliferation

It can be confusing to know whether tirzepatide or semaglutide will benefit you and your health. While similar, they differ in how they work and how they’re dosed. Tirzepatide is approved by the U.S. Food and Drug Administration (FDA) for: -Type 2 diabetes in adults and https://t.co/mAcSpEXklu

RT @DailyPeptide: Peptides ranked by category (fight me): 🔥 fat loss 1.Retatrutide 2.Tirzepatide 3.Semaglutide 💪 recovery 1.BPC-157 2.TB-…

5 popular peptides in 2026 and what they do: BPC-157 - studied for tissue repair TB-500 - studied for recovery, mobility Tirzepatide - dual GIP/GLP-1 agonist CJC-1295 / Ipamorelin - GH secretagogue pairing GHK-Cu - studied for skin, collagen

Asked your primary care doc about BPC-157 and got a blank stare or a flat no? You're not crazy, and it's not personal. Your doctor legally CAN'T prescribe it through a normal pharmacy right now, and here's the actual machinery, because nobody explains it. There are three real

Every compound in stock right now: METABOLIC → GLP-3RT · Semaglutide · Tirzepatide GROWTH HORMONE → HGH · CJC-1295 · Ipamorelin → Tesamorelin · IGF-1 LR3 RECOVERY → BPC-157 · TB-500 · KPV · ARA-290 LONGEVITY → NAD+ · GHK-Cu · Epithalon · MOTS-C NOOTROPICS → Semax ·

Every compound in stock right now: METABOLIC → GLP-3RT · Semaglutide · Tirzepatide GROWTH HORMONE → HGH · CJC-1295 · Ipamorelin → Tesamorelin · IGF-1 LR3 RECOVERY → BPC-157 · TB-500 · KPV · ARA-290 LONGEVITY → NAD+ · GHK-Cu · Epithalon · MOTS-C NOOTROPICS → Semax ·

Do you agree that peptides should continue to be classified strictly as prescription-only medications, or should they eventually transition to over-the-counter supplements? Let us know your thoughts in the comments below! https://t.co/d4da71ZH1s

3/12 — WHICH PEPTIDES ARE ACTUALLY FDA-APPROVED This surprises people, so let me be specific. Approved metabolic peptides: semaglutide (Ozempic, Wegovy, Rybelsus), tirzepatide (Mounjaro, Zepbound), liraglutide (Victoza, Saxenda). Approved for specific indications: tesamorelin